| Not Yet Recruiting | NT-3 Levels and Function in Individuals With CMT NCT05011006 | Zarife Sahenk | — |
| Recruiting | Genotype/Phenotype Correlation of MORC2 Mutations NCT07038239 | Hospices Civils de Lyon | — |
| Recruiting | High-Tech Rehabilitation Pathway for Chronic Adult Neuromuscular Diseases - Fit4MedRob-Chronic MND Project NCT06881979 | Istituti Clinici Scientifici Maugeri SpA | N/A |
| Completed | Safety and Efficacy of NMD670 in Adult Patients With Type 1 and Type 2 Charcot-Marie-Tooth Disease NCT06482437 | NMD Pharma A/S | Phase 2 |
| Recruiting | Charcot-Marie-Tooth Disease (CMT) Biological Sample Collection for IPSC Generation and Biobanking NCT06203093 | New York Stem Cell Foundation Research Institute | — |
| Completed | EVALUATION OF SERUM INFLAMMATORY CYTOKINE CONCENTRATION IN HEREDITARY SENSITIVOMOTOR NEUROPATHIES NCT06808581 | Centre Hospitalier Universitaire de Nice | N/A |
| Completed | Observational Study of Neuromuscular Function in CMT Type 1&2 and Healthy Controls NCT04980807 | NMD Pharma A/S | — |
| Completed | Validation Study of Posturology Platforms for Evaluating Postural Control of Hemiparetic and Neuro-muscular Pa NCT04283175 | Assistance Publique - Hôpitaux de Paris | — |
| Active Not Recruiting | Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients NCT04762758 | Pharnext S.C.A. | Phase 3 |
| Completed | Irisin Levels in Patients With Charcot-Marie-Tooth (CMT) Disease NCT04786522 | University of Bari | — |
| Terminated | A Natural History Study of Charcot-Marie-Tooth 4J (CMT4J) NCT03810508 | Neurogene Inc. | — |
| Recruiting | A Registered Cohort Study on Charcot-Marie-Tooth Disease NCT04010188 | Ning Wang, MD., PhD. | — |
| Terminated | Extension Study to Evaluate the Long-Term Effects of ACE-083 in Patients With Facioscapulohumeral Muscular Dys NCT03943290 | Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA | Phase 2 |
| Completed | Change in MUNIX in Patients With CMT1A Undergoing a Home Ankle Strengthening Program Versus Standard of Care NCT03715283 | Vanderbilt University Medical Center | N/A |
| Completed | The Impact of Charcot-Marie-Tooth Disease in the Real World NCT03782883 | Vitaccess Ltd | — |
| Terminated | Hearing and Balance Disorders in Peripheral Neuropathy NCT05827419 | Nemours Children's Clinic | — |
| Recruiting | Observational Study to Observe Variations of Gait Parameters in Patients With Neuromuscular Diseases NCT06666816 | IRCCS Eugenio Medea | — |
| Terminated | A Study to Assess the Safety and Effectiveness of FLX-787 in Subjects With Charcot-Marie-Tooth Disease Experie NCT03254199 | Flex Pharma, Inc. | Phase 2 |
| Terminated | Study of ACE-083 in Patients With Charcot-Marie-Tooth Disease NCT03124459 | Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA | Phase 2 |
| Completed | SERENDEM : MD1003 in Patients Suffering From Demyelinating Neuropathies, an Open Label Pilot Study NCT02967679 | MedDay Pharmaceuticals SA | Phase 2 |
| Unknown | Charcot-Marie-Tooth Disease (CMT) Infant Scale (INC-6611) NCT02979145 | Sydney Children's Hospitals Network | — |
| Completed | Patient Reported Outcomes Measures (PROM) in Carpal Tunnel Therapies in Patients With Inherited Neuropathies NCT02788734 | University of South Florida | — |
| Completed | Mexiletine for Muscle Cramps in Charcot Marie Tooth Disease NCT02561702 | University of Rochester | Phase 2 |
| Completed | Genetics of Pediatric-Onset Motor Neuron and Neuromuscular Diseases NCT02532244 | Nemours Children's Clinic | — |
| Completed | Disability Severity Scale (DSI) and Hereditary Motor and Sensory Neuropathy Overall Disability Scale (HMSN-R-O NCT02194010 | University of Iowa | — |
| Recruiting | Natural History Study for Charcot Marie Tooth Disease NCT05902351 | Hereditary Neuropathy Foundation | — |
| Completed | Study of Electrical Impedance Myography (EIM) in ALS NCT02011204 | Skulpt, Inc. | — |
| Completed | Survey of Current Management of Orthopaedic Complications in CMT Patients NCT02001038 | University College London Hospitals | — |
| Unknown | Evaluation of the Analgesic Efficiency of the Transcutaneous Neurostimulation in the Charcot Syndrome Marie To NCT01918826 | Centre Hospitalier Universitaire de Nice | N/A |
| Completed | Development and Validation of a Disability Severity Index for CMT NCT01455623 | University of Iowa | — |
| Unknown | Treadmill, Stretching and Proprioceptive Exercise (TreSPE) Rehabilitation Program for Charcot-Marie-Tooth Neur NCT01289704 | University of Genova | Phase 2 / Phase 3 |
| Completed | Phase II, Randomized, Placebo-controlled Trial in Patients With Charcot-marie-tooth Disease Type 1A NCT01401257 | Pharnext S.C.A. | Phase 2 |
| Recruiting | Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others NCT01193075 | Michael Shy | — |
| Completed | Development of Charcot Marie Tooth Disease (CMT) Pediatric Scale for Children With CMT NCT01203085 | University of Iowa | — |
| Completed | Effects of Coenzyme Q10 on Charcot-Marie-Tooth Disease NCT00541164 | Memorial Medical Center | Phase 1 / Phase 2 |
| Completed | Ascorbic Acid Treatment in CMT1A Trial (AATIC) NCT00271635 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Phase 2 |
| Completed | Follow up and Observation of Charcot Marie Tooth Disease in Families NCT00149045 | Hadassah Medical Organization | — |